Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia

被引:299
作者
Lee, PJ
Alam, J
Wiegand, GW
Choi, AMK
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DIV PULM & CRIT CARE, BALTIMORE, MD 21205 USA
[2] JOHNS HOPKINS UNIV, SCH MED, DIV CLIN & MOL RHEUMATOL, BALTIMORE, MD 21205 USA
[3] ALTON OCHSNER MED FDN & OCHSNER CLIN, DEPT MOL GENET, NEW ORLEANS, LA 70121 USA
[4] LOUISIANA STATE UNIV, MED CTR, DEPT BIOCHEM & MOL BIOL, NEW ORLEANS, LA 70121 USA
关键词
D O I
10.1073/pnas.93.19.10393
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Heme oxygenase (HO) catalyzes the rate-limiting step in the degradation of heme to biliverdin, which is reduced by biliverdin reductase to bilirubin, Heme oxygenase-1 (HO-1) is inducible not only by its heme substrate, but also by a variety of agents causing oxidative stress, Although much is known about the regulation of HO-1 expression, the functional significance of HO-1 induction after oxidant insult is still poorly understood, We hypothesize and provide evidence that HO-1 induction serves to protect cells against oxidant stress. Human pulmonary epithelial cells (A549 cells) stably transfected with the rat HO-1 cDNA exhibit marked increases of HO-1 mRNA levels which were correlated with increased HO enzyme activity, Cells that overexpress HO-1 (A549-A4) exhibited a marked decrease in cell growth compared with wild-type A549 (A549-WT) cells or A549 cells transfected with control DNA (A549-neo), This slowing of cell growth was associated with an increased number of cells in G(0)/G(1) phase during the exponential growth phase and decreased entry into the S phase, as determined by flow cytometric analysis of propidium iodide-stained cells and pulse experiments with bromodeoxyuridine, Furthermore, the A549-A4 cells accumulated at the G(2)/M phase and failed to progress through the cell cycle when stimulated with serum, whereas the A549-neo control cells exhibited normal cell cycle progression, interestingly, the A549-A4 cells also exhibited marked resistance to hyperoxic oxidant insult, Tin protoporphyrin, a selective inhibitor of HO, reversed the growth arrest and ablated the increased survival against hyperoxia observed in the A549-A4 cells overexpressing HO-1, Taken together, our data suggest that overexpression of HO-1 results in cell growth arrest, which may facilitate cellular protection against non-heme-mediated oxidant insult such as hyperoxia.
引用
收藏
页码:10393 / 10398
页数:6
相关论文
共 40 条
[22]   OXYGEN-TOXICITY - AUGMENTATION OF ANTIOXIDANT DEFENSE-MECHANISMS IN RAT LUNG [J].
KIMBALL, RE ;
REDDY, K ;
PEIRCE, TH ;
SCHWARTZ, LW ;
MUSTAFA, MG ;
CROSS, CE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1976, 230 (05) :1425-1431
[23]  
KUTTY RK, 1994, J CELL PHYSIOL, V159, P371
[24]   ENDOGENOUS GLUTATHIONE LEVELS MODULATE BOTH CONSTITUTIVE AND UVA RADIATION HYDROGEN-PEROXIDE INDUCIBLE EXPRESSION OF THE HUMAN HEME OXYGENASE GENE [J].
LAUTIER, D ;
LUSCHER, P ;
TYRRELL, RM .
CARCINOGENESIS, 1992, 13 (02) :227-232
[25]   Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury [J].
Lee, PJ ;
Alam, J ;
Sylvester, SL ;
Inamdar, N ;
Otterbein, L ;
Choi, AMK .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1996, 14 (06) :556-568
[26]   OVEREXPRESSION OF MANGANOUS SUPEROXIDE-DISMUTASE (MNSOD) IN PULMONARY ENDOTHELIAL-CELLS CONFERS RESISTANCE TO HYPEROXIA [J].
LINDAUSHEPARD, B ;
SHAFFER, JB ;
DELVECCHIO, PJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 1994, 161 (02) :237-242
[27]   HEME OXYGENASE - FUNCTION, MULTIPLICITY, REGULATORY MECHANISMS, AND CLINICAL-APPLICATIONS [J].
MAINES, MD .
FASEB JOURNAL, 1988, 2 (10) :2557-2568
[28]  
MITANI K, 1992, BLOOD, V79, P1255
[29]   CREATIVE BLOCKS - CELL-CYCLE CHECKPOINTS AND FEEDBACK CONTROLS [J].
MURRAY, AW .
NATURE, 1992, 359 (6396) :599-604
[30]   INDUCTION OF HEME OXYGENASE IS A RAPID, PROTECTIVE RESPONSE IN RHABDOMYOLYSIS IN THE RAT [J].
NATH, KA ;
BALLA, G ;
VERCELLOTTI, GM ;
BALLA, J ;
JACOB, HS ;
LEVITT, MD ;
ROSENBERG, ME .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :267-270